ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Vermont » Family Medicine

Top Family Medicine Prescribers in Vermont

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
STEPHEN ROSMUS MD

Family Medicine

6,571

$383K

302
242 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

7%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$58
Average prescription price

Avg: $63

ROBERT SCHWARTZ MD

Family Medicine

6,463

$275K

282
215 are 65+

5%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 23%

$43
Average prescription price

Avg: $63

TOBY SADKIN MD

Family Medicine

6,433

$371K

280
178 are 65+

6%
patients receiving schedule two controlled substances

Avg: 8%

9%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$58
Average prescription price

Avg: $63

PAUL LAFFAL MD

Family Medicine

6,388

$323K

239
168 are 65+

8%
patients receiving schedule two controlled substances

Avg: 8%

10%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 23%

$51
Average prescription price

Avg: $63

JULIE FOSTER MD

Family Medicine

6,374

$366K

226
183 are 65+

5%
patients receiving schedule two controlled substances

Avg: 8%

9%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$57
Average prescription price

Avg: $63

JOYCE DOBBERTIN M.D.,D.C.

Family Medicine

6,274

$425K

376
305 are 65+

15%
patients receiving schedule two controlled substances

Avg: 8%

9%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$68
Average prescription price

Avg: $63

EDD LYON MD

Family Medicine

6,267

$352K

316
239 are 65+

4%
patients receiving schedule two controlled substances

Avg: 8%

6%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$56
Average prescription price

Avg: $63

JOSEPH BROCK MD

Family Medicine

6,263

$398K

309
169 are 65+

14%
patients receiving schedule two controlled substances

Avg: 8%

21%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$64
Average prescription price

Avg: $63

STEPHEN GENEREAUX M.D.

Family Medicine

6,155

$265K

203
172 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

7%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 23%

$43
Average prescription price

Avg: $63

TIMOTHY BICKNELL MD

Family Medicine

6,057

$450K

401
321 are 65+

12%
patients receiving schedule two controlled substances

Avg: 8%

7%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$74
Average prescription price

Avg: $63

FRANCIS COOK M.D.

Family Medicine

6,052

$320K

353
274 are 65+

10%
patients receiving schedule two controlled substances

Avg: 8%

4%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$53
Average prescription price

Avg: $63

SCOTT SMITH MD

Family Medicine

5,937

$346K

319
238 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

7%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 23%

$58
Average prescription price

Avg: $63

MAURICE GEURTS M.D.

Family Medicine

5,933

$431K

272
196 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

12%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$73
Average prescription price

Avg: $63

BARBARA RASKIN MD

Family Medicine

5,917

$333K

277
212 are 65+

6%
patients receiving schedule two controlled substances

Avg: 8%

4%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$56
Average prescription price

Avg: $63

PHILIP KIELY M.D.

Family Medicine

5,807

$472K

307
225 are 65+

17%
patients receiving schedule two controlled substances

Avg: 8%

18%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$81
Average prescription price

Avg: $63

JOHN SCOTT M.D., PH.D.

Family Medicine

5,698

$393K

435
326 are 65+

14%
patients receiving schedule two controlled substances

Avg: 8%

14%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 23%

$69
Average prescription price

Avg: $63

THOMAS CURCHIN MD

Family Medicine

5,653

$371K

269
178 are 65+

15%
patients receiving schedule two controlled substances

Avg: 8%

10%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 23%

$66
Average prescription price

Avg: $63

JOHN LIPPMANN MD

Family Medicine

5,603

$410K

263
186 are 65+

12%
patients receiving schedule two controlled substances

Avg: 8%

9%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$73
Average prescription price

Avg: $63

J. GREGORY KING MD

Family Medicine

5,580

$491K

266
163 are 65+

12%
patients receiving schedule two controlled substances

Avg: 8%

9%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 23%

$88
Average prescription price

Avg: $63

MAX BAYARD MD

Family Medicine

5,467

$254K

275
197 are 65+

6%
patients receiving schedule two controlled substances

Avg: 8%

10%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 23%

$47
Average prescription price

Avg: $63

ROBERT SCHWARTZ MD

Family Medicine

5,452

$352K

434
355 are 65+

8%
patients receiving schedule two controlled substances

Avg: 8%

7%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$65
Average prescription price

Avg: $63

DAVID BISBEE M.D.

Family Medicine

5,371

$287K

262
190 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

12%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 23%

$53
Average prescription price

Avg: $63

DAVID ROY MD

Family Medicine

5,313

$492K

283
184 are 65+

13%
patients receiving schedule two controlled substances

Avg: 8%

16%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$93
Average prescription price

Avg: $63

BEVERLY ROSEBERRY MD

Family Medicine

5,236

$305K

280
242 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

5%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 23%

$58
Average prescription price

Avg: $63

PETER HOGENKAMP MD

Family Medicine

5,229

$343K

288
269 are 65+

5%
patients receiving schedule two controlled substances

Avg: 8%

6%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 23%

$66
Average prescription price

Avg: $63

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank